Learn More
CONTEXT Splenic marginal zone lymphoma (SMZL) is a lymphoproliferative B-cell disorder that has a favorable prognosis, with estimated overall five-year survival of 70%. The majority of symptomatic(More)
e16525 Background: Treatment of metastatic lung cancer has improved significantly over the last 2 decades. Unfortunately, many of the new treatments are expensive and inaccessible to most patients(More)